Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2 is a research paper published in ACS Pharmacology & Translational Science (2022). On theSindex it has a DataRank of 0. It has been cited 62 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA218600
National Cancer Institute
Grant: R01CA230854
National Cancer Institute
Grant: R01CA268519
Icahn School of Medicine at Mount Sinai
Grant: T32GM007280
National Institutes of Health
Grant: 1S10OD025132
National Institutes of Health
Grant: 1S10OD028504
National Institutes of Health
Grant: 3R01CA230854S1
NIH HHS
Grant: S10 OD028504
NIH HHS
Grant: S10 OD025132
FWCI
4.45
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals